Comparison of the effects of omeprazole and famotidine in treatment of upper abdominal symptoms in patients with reflux esophagitis

Journal of Gastroenterology

Volumn 44, Issue 4, 2009, Pages 261-270

  Kusunoki, Hiroaki ^a   Kusaka, Masayasu ^b   Kido, Soichiro ^c   Yamauchi, Ryo ^d   Fujimura, Yoshinori ^a   Watanabe, Yasuyuki ^e   Kobori, Michio ^f   Miwa, Hiroto ^g   Tomita, Toshihiko ^g   Kin, Yongmin ^g   Hori, Kazutoshi ^g   Tano, Nobuo ^h   Sugimoto, Kenji ⁱ   Nakamura, Yoshihiro ^j   Fujimoto, Kazuma ^k   Oza, Noriko ^k   Matsunobu, Aki ^l   Ono, Naofumi ^l   Fuyuno, Seisuke ^m   Kinoshita, Yoshikazu ⁿ   Adachi, Kyoichi ⁿ   Yuki, Mika ^o   Fujisawa, Tomoo ^p   Haruma, Ken ^a   more..

^a KAWASAKI MEDICAL SCHOOL   (Japan)

^b Kusaka Hospital   (Japan)

^c HIROSHIMA GENERAL HOSPITAL   (Japan)

^d Mitsubishi Mihara Hospital   (Japan)

^e Watanabe Clinic   (Japan)

^f Department of Internal Medicine   (Japan)

^g HYOGO COLLEGE OF MEDICINE   (Japan)

^h Kyoritsu Hospital   (Japan)

ⁱ Sugimoto Kenji Clinic   (Japan)

^j Kyowa Marina Hospital   (Japan)

^k SAGA UNIVERSITY   (Japan)

^l Eguchi Hospital   (Japan)

^m Fuyuno Hospital   (Japan)

ⁿ SHIMANE UNIVERSITY FACULTY OF MEDICINE   (Japan)

^o Izumo City General Medical Center   (Japan)

^p MATSUE RED CROSS HOSPITAL   (Japan)

more..

Author keywords

Famotidine; Omeprazole; Upper abdominal symptoms

Indexed keywords

FAMOTIDINE; OMEPRAZOLE;

ABDOMINAL DISCOMFORT; ADULT; AGED; ANOREXIA; ARTICLE; BURNING SENSATION; CLINICAL TRIAL; CONSTIPATION; DIARRHEA; DRUG EFFICACY; FEMALE; GASTROESOPHAGEAL REFLUX; HEARTBURN; HUMAN; INDIGESTION; JAPAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; PATIENT COMPLIANCE; PRIORITY JOURNAL; QUESTIONNAIRE; RATING SCALE; REFLUX ESOPHAGITIS; STOMACH ACID; THROAT DISEASE; TREATMENT DURATION; TREATMENT OUTCOME; UPPER ABDOMINAL PAIN; VOMITING;

ADULT; AGED; ANTI-ULCER AGENTS; ESOPHAGITIS, PEPTIC; FAMOTIDINE; FEMALE; HISTAMINE H2 ANTAGONISTS; HUMANS; MALE; MIDDLE AGED; OMEPRAZOLE; PROTON PUMP INHIBITORS; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 65049089659     PISSN: 09441174     EISSN: 14355922     Source Type: Journal    
DOI: 10.1007/s00535-009-0003-4     Document Type: Article

References (32)

1. Suzuki H, Hibi T, Marshall BJ. Helicobacter pylori: Present status and future prospects in Japan. J Gastroenterol. 2007;42:1-15.
2. Stanghellini V. Three-month prevalence rate of gastrointestinal symptoms and the influence of demographic factors: Results from the Domestic/ International Gastroenterology Surveillance (DIGEST). Scand J Gastroenterol. 1999;231:20-8.
3. Tougas G, Chen Y, Hwang P, Liu MM, Eggleston A. Prevalence and impact of upper gastrointestinal symptoms in the Canadian population: Findings from the DIGEST study. Am J Gastroenterol. 1999;94:2845-54.
4. Thomson ABR, Barkun AN, Armstrong D, Chiba N, White RJ, Daniels S, et al. The prevalence of clinically significant upper gastrointestinal findings in primary care patients with uninvestigated dyspepsia: The Canadian adult dyspepsia empiric treatment-prompt endoscopy (CADET-PE) study. Aliment Pharmacol Ther. 2003;17:1481-91.
5. Tack J, Talley NJ, Camilleri M, Holtmann G, Hu P, Malagelada J, et al. Functional gastroduodenal disorders. Gastroenterology. 2006;130(5):1466-79.
6. Suzuki H, Nishizawa T, Hibi T. Therapeutic strategies for functional dyspepsia and the information of the Rome III classification. J Gastroenterol. 2006;41:513-23.
7. Talley NJ, Vakil N. Guidelines for management of dyspepsia. Am J Gastroenterol. 2005;100:2324-37.
8. Veldhuyzen van Zanten SJO, Chiba N, Armstrong D, Barkun A, Thomson A, Smyth S, et al. A randomized trial comparing omeprazole, ranitidine, cisapride, or placebo in helicobacter pylori negative, primary care physicians with dyspepsia: The CADET-HN study. Am J Gastroenterol. 2005;100:1477-88.
9. Mason I, Millar LJ, Sheikh RR, Evans WMI, Todd PL, Turbitt ML, et al. The management of acid-related dyspepsia in general practice: A comparison of an omeprazole versus an antacid-alginate/ranitidine management strategy. Compete Research Group [corrected]. Aliment Pharmacol Ther. 1998;12(3):263-71.
10. Hongo M, Kanatsuka H, Sugawara A, Nagasaki Y, Endo Y, Karahashi K, et al. Primary care in the treatment of functional gastrointestinal symptoms in Japan: Prescription preferences and impression of results. Aliment Pharmacol Ther. 2005;21:47-54.
11. Adachi K, Matsumori Y, Fujisawa T, Kamada T, Kusaka M, Ohumi T, et al. Symptom diversity of patients with reflux esophagitis: Effect of omeprazole treatment. J Clin Biochem Nutr. 2006;39:46-54.
12. Armstrong D, Bennett JR, Blum AL, Dent J, Dombal T, Galmiche JP, et al. The endoscopic assessment of esophagitis: A progress report on observer agreement. Gastroenterology. 1996;111:85-92.
13. Laheij RJ, De Koning RW, Horrevorts AM, Rongen RJ, Leo Rossum GM, Wittenman EM, et al. Predominant symptom behavior in patients with persistent dyspepsia during treatment. J Clin Gastroenterol. 2004;38:490-5.
14. Chiba N. Treat the patients' main dyspepsia complaint, not the ROME criteria. Am J Gastroenterol. 2004;99(6):1059-62.
15. van Zanten SV, Armstrong D, Chiba N, et al. Esomeprazole 40 mg once a day in patients with functional dyspepsia: The randomized, placebo-controlled "ENTER" trial. Am J Gastroenterol. 2006;101(9):2096-106.
16. Talley NJ, Stanghellini V, Heading RC, Koch KL, Malagelada JR, Tytgat GN. Functional gastroduodenal disorders. Gut. 1999;45:II37-42.
17. Quigley EMM. Motility, heartburn and dyspepsia. Aliment Pharmacol Ther. 1997;11:41-50.
18. Penagini R, Hebbard G, Horowitz M, Dent J, Bermingham H, Jones K, et al. Motor function of the proximal stomach and visceral perception in patients with gastroesophageal reflux disease. Gut. 1998;42:251-7.
19. Tosetti C, Stanghellini V, Tucci A, Poli L, Salvioli B, Biasco G, et al. Gastric emptying and dyspeptic symptoms in patients with nonautoimmune fundic atrophic gastritis. Dig Dis Sci. 2000;45(2):252-7.
20. Tucci A, Poli L, Tosetti C, Biasco G, Grigioni W, Varoli O, et al. Reversal of fundic atrophy after eradication of Helicobacter pylori. Am J Gastroenterol. 1998;93(9):1425-31.
21. Ebara S, Shirasaka D, Aoyama N, Kachi M, Miki I, Morita Y, et al. The relationship between gastric emptying determined by the breath test and H. pylori. Hepatogastroenterology. 2007;54:613-6.
22. Suzuki H, Masaoka T, Sakai G, Ishii H, Hibi T. Improvement of gastrointestinal quality of life in cases of Helicobacter pylori -positive functional dyspepsia after successful eradication therapy. J Gastroenterol Hepatol. 2005;20:1652-60.
23. William DC, Benjamin CYW. American college of gastroenterology guideline on the management of Helicobacter pylori infection. Am J Gastroenterol. 2007;102:1808-25.
24. Samsom M, Verhagen M, Henegouwen G, Smout A. Abnormal clearance of exogenous acid and increased acid sensitivity of the proximal duodenum in dyspeptic patients. Gastroenterology. 1999;116(3):515-20.
25. Miwa H, Nakajima K, Yamaguchi K, Fujimoto K, Veldhuyzen VAN, Zanten SJ, et al. Generation of dyspeptic symptoms by direct acid infusion into the stomach of healthy Japanese subjects. Aliment Pharmacol Ther. 2007;26(2):257-64.
26. Simren M, Vos R, Janssens J, Tack J. Acid infusion enhances duodenal mechanosensitivity in healthy subjects. Am J Physiol Gastrointest Liver Physiol. 2003;285(2):G309-15.
27. Lee KJ, Vos R, Janssens J, Tack J. Influence of duodenal acidification on the sensorimotor function of the proximal stomach in humans. Am J Physiol Gastrointest Liver Physiol. 2004;286(2):G278-84.
28. Coffin B, Chollet R, Flourie B, Lemann M, Franchisseur C, Rambaud JC, et al. Intraluminal modulation of gastric sensitivity to distension: effects of hydrochloric acid and meal. Am J Physiol Gastrointest Liver Physiol. 2001;280(5):G904-9.
29. Hunt JN, Knox MT. The slowing of gastric emptying by four strong acids and three weak acids. J Physiol. 1972;222(1):187-208.
30. Hansen AN, Bergheim R, Fagertun H, Lund H, Wiklund I, Moum B. Long-term management of patients with symptoms of gastro-oesophageal reflux disease - a Norwegian randomised prospective study comparing the effects of esomeprazole and ranitidine treatment strategies on health-related quality of life in a general practitioners setting. Int J Clin Pract. 2006;60(1):15-22.
31. Dimenäs E, Glise E, Hallebäck B, Hernqvist H, Svedlund J, Wiklund I. Well-being and gastrointestinal symptoms among patients referred to endoscopy owing to suspected duodenal ulcer. Scand J Gastroenterol. 1995;30:1046-52.
32. Dimenäs E, Carlsson G, Glise H, Israelsson B, Wiklund I. Relevance of norm values as part of the documentation of quality of life instruments for use in upper gastrointestinal disease. Scand J Gastroenterol Suppl. 1996;221:8-13.